1076 - 1100 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Genomewide association study for onset age in Parkinson diseaseJournal Name: BMC Medical GeneticsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2350-10-98Best OA location URL: https://bmcmedgenet.biomedcentral.com/counter/pdf/10.1186/1471-2350-10-98Citation Count: 107
-
RESTRICTEDTitle: The Role of Rab Proteins in Parkinson’s Disease SynaptopathyJournal Name: BiomedicinesPublisher: MDPI AGVol: 10Issue #: 8Start Page: 1941End Page: 1941Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines10081941Best OA location URL: https://www.mdpi.com/2227-9059/10/8/1941/pdf?version=1660634425Citation Count: 15
-
RESTRICTEDTitle: Consensus Paper: Experimental Neurostimulation of the CerebellumJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 6Start Page: 1064End Page: 1097Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-019-01041-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-019-01041-5.pdfCitation Count: 126
-
RESTRICTEDTitle: LRRK2 and Lipid Pathways: Implications for Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 11Start Page: 1597End Page: 1597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12111597Best OA location URL: https://www.mdpi.com/2218-273X/12/11/1597/pdf?version=1667112107Citation Count: 8
-
RESTRICTEDTitle: The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 10Issue #: 6Start Page: 912End Page: 912Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom10060912Best OA location URL: https://www.mdpi.com/2218-273X/10/6/912/pdf?version=1593094633Citation Count: 21
-
RESTRICTEDTitle: Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes NeurotoxicJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 60Issue #: 17Start Page: 9215End Page: 9246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/anie.202000451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202000451Citation Count: 87
-
RESTRICTEDTitle: The role of the basal ganglia in learning and memory: Insight from Parkinson’s diseaseJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 96Issue #: 4Start Page: 624End Page: 636Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2011.08.006Best OA location URL: https://europepmc.org/articles/pmc3772079?pdf=renderCitation Count: 157
- Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms2022RESTRICTEDTitle: Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanismsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105580End Page: 105580Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105580Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105580Citation Count: 21
-
RESTRICTEDTitle: Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105088End Page: 105088Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105088Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105088Citation Count: 4
-
RESTRICTEDTitle: Chipping away at diagnostics for neurodegenerative diseasesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 35Issue #: 2Start Page: 148End Page: 156Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.02.016Best OA location URL: https://europepmc.org/articles/pmc2753504?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian modelsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 57Issue #:Start Page: 38End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.06.025Best OA location URL: https://europepmc.org/articles/pmc3815566?pdf=renderCitation Count: 152
-
RESTRICTEDTitle: No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 74Issue #:Start Page: 236.e1End Page: 236.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.022Best OA location URL: http://manuscript.elsevier.com/S0197458018303476/pdf/S0197458018303476.pdfCitation Count: 1
-
RESTRICTEDTitle: Proteostasis control by the unfolded protein responseJournal Name: Nature Cell BiologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 7Start Page: 829End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncb3184Best OA location URL: https://europepmc.org/articles/pmc5546321?pdf=renderCitation Count: 590
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 97
-
RESTRICTEDTitle: Prospects of Statins in Parkinson DiseaseJournal Name: The NeuroscientistPublisher: SAGE PublicationsVol: 17Issue #: 3Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073858410385006Best OA location URL: https://europepmc.org/articles/pmc3132406?pdf=renderCitation Count: 86
-
RESTRICTEDTitle: α-Synuclein and Mitochondria: Partners in Crime?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0182-9Best OA location URL: https://europepmc.org/articles/pmc3701775?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: Intrabodies as Neuroprotective TherapeuticsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 447End Page: 458Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0193-6Best OA location URL: https://europepmc.org/articles/pmc3701772?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
-
RESTRICTEDTitle: Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic ModalitiesJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0211-8Best OA location URL: https://europepmc.org/articles/pmc3805874?pdf=renderCitation Count: 73
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
RESTRICTEDTitle: Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 148End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0497-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0497-4.pdfCitation Count: 74
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17
-
RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27